ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Inflammation"

  • Abstract Number: 2257 • 2016 ACR/ARHP Annual Meeting

    Regulation of Mitochondrial Proton Gradient Is Critical for NLRP3 Inflammasome Activation

    Jehad H. Edwan, Raphaela Goldbach-Mansky and Robert A. Colbert, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

    Background/Purpose:  Self-activating mutations in NLRP3 cause a spectrum of autoinflammatory diseases known as cryopyrin-associated periodic syndromes (CAPS). NLRP3 is a key component of a multiprotein…
  • Abstract Number: 159 • 2016 ACR/ARHP Annual Meeting

    Assessing Agreement Among Measures of Inflammation Detected on Magnetic Resonance Imaging, Ultrasound and Clinical Findings in the Feet of Patients with Early Rheumatoid Arthritis

    Karen A. Beattie1, George Ioannidis2, Sydney Scheffler3, Saara Totterman4, Edward Schreyer5 and Maggie Larche1, 1Medicine, McMaster University, Hamilton, ON, Canada, 2St Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 3McMaster University, Hamilton, ON, Canada, 4Radiology, VirtualScopics Inc., Rochester, NY, 5QMetrics Technologies, Rochester, NY

    Background/Purpose: In metatarsalphalangeal (MTP) joints 2-5 of patients with early rheumatoid arthritis (RA), we aimed to assess the agreement between i) Magnetic Resonance Imaging (MRI)…
  • Abstract Number: 1125 • 2016 ACR/ARHP Annual Meeting

    Targeted Lipidomics Reveals Incomplete Activation of Resolution Pathways in Knee Osteoarthritis

    Hulda Jonasdottir1, Hilde Brouwers2, Mukundan Attur3, Joanneke Kwekkeboom2, Jonathan Samuels3, Eric Strauss4, Enrike van der Linden-van der Zwaag5, TWJ Huizinga6, M. Kloppenburg7, REM Toes8, Martin Giera9, Steven B. Abramson3 and Andreea Ioan-Facsinay2, 1Center for Proteomics and Metabolomics, Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Department of Medicine, NYU School of Medicine, NYU Langone Medical Center, New York, NY, 4Department of Orthopedic Surgery, NYU School of Medicine, NYU Langone Medical Center, New York, NY, 5Department of Orthopaedics, Leiden University Medical Center, Leiden, Netherlands, 6Leiden University Medical Centre, Leiden, Netherlands, 7Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands, 8Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 9Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Persistent inflammation is a characteristic of several joint diseases, including OA. It is nowadays appreciated that this could be a result of a failure…
  • Abstract Number: 2263 • 2016 ACR/ARHP Annual Meeting

    Apolipoprotein E Regulates Inflammation and Joint Destruction during Antigen-Induced Arthritis (AIA)

    Giuliana Ascone1, Irene Di Ceglie1, Wouter de Munter1, Birgitte Walgreen2, Annet Sloetjes1, Peter M. van der Kraan1, Ernst Lindhout3, Mike Martens3 and Peter L. E. M. van Lent1, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 2Experimental, Radboud university medical center, Nijmegen, Netherlands, 3Future Diagnostics Solutions (FDs), Wijchen, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease largely driven by immune complexes and their interaction with FcγRs present on macrophages within the synovium.…
  • Abstract Number: 167 • 2016 ACR/ARHP Annual Meeting

    Bone Mineral Density Loss in Clinically Suspect Arthralgia Is Associated with Subclinical Inflammation and Progression to Clinical Arthritis

    L. Mangnus1, H.W. van Steenbergen2, M. Reijnierse3, J. Kälvesten4,5,6 and A.H.M. van der Helm-van Mil2, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Radiology, Leiden University Medical Center, Leiden, Netherlands, 4Radiology, Faculty of Health Sciences, Linköping, Sweden, 5Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden, 6Sectra AB, Linköping, Sweden

    Background/Purpose: Peripheral bone mineral density (BMD) can be decreased in early rheumatoid arthritis but it is unknown if BMD loss emerges already before arthritis is…
  • Abstract Number: 1434 • 2016 ACR/ARHP Annual Meeting

    Effect of Systemic and Local Inflammation on the Insulin Resistance and Glucose/Lipid Metabolism in Rheumatoid Arthritis: Humans and CIA Mouse Model

    Nuria Barbarroja1, IVÁN ARIAS DE LA ROSA1, Manuel Peña1, Sergio Rodriguez-Cuenca2, Yolanda Jiménez-Gómez1, Patricia Ruiz-Limon3, Carlos Perez-Sanchez1, Maria Carmen Abalos-Aguilera3, Jerusalem Calvo-Gutierrez1, Eduardo Collantes-Estévez1, Antonio Vidal-Puig2, Chary Lopez-Pedrera1 and Alejandro Escudero-Contreras1, 1Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 2Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbroke’s Hospital, University of Cambridge, Cambridge, United Kingdom, 3Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain

    Background/Purpose:  Rheumatoid arthritis (RA) patients are at higher risk for insulin resistance (IR). The association between RA and IR, and its role on the different…
  • Abstract Number: 2264 • 2016 ACR/ARHP Annual Meeting

    Lack of Obesity-Related Changes in Adipocytes and Inflammatory Cells in the Infrapatellar Fat Pad (IFP): A Different Type of Fat?

    Anja de Jong1, I.R. klein-Wieringa1, Stefan Andersen2, Joanneke Kwekkeboom1, Linda van Toorn1, Badelog de Lange1, Danny van Delft3, John Garcia4, Wu Wei5, Huub van der Heide3, Yvonne Bastiaansen-Jenniskens4, Gerjo van Osch4, Anne-Marie Zuurmond6, Vedrana Stojanovic-Susulic7, Rob Nelissen3, René Toes1, Margreet Kloppenburg1 and Andreea Ioan-Facsinay1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Charles River Nederland B.V., Leiden, Netherlands, 3Orthopaedics, Leiden University Medical Center, Leiden, Netherlands, 4Orthopaedics, Erasmus MC, Rotterdam, Netherlands, 5Orthopaedics, Erasmus MC, rotterdam, Netherlands, 6TNO, Leiden, Netherlands, 7Janssen, Pharmaceutical Companies Johnson & Johnson, Springhouse, PA

    Background/Purpose: Obesity is associated with the development and progression of osteoarthritis (OA). Although the mechanisms involved in this association are poorly understood, it is well…
  • Abstract Number: 954 • 2015 ACR/ARHP Annual Meeting

    The Relationship Between Osteoarthritis and Cardiovascular Disease: Results from a Population-Based Cohort

    Lauren King1, Tetyana Kendzerska1,2,3 and Gillian Hawker1,2,3, 1Department of Medicine, University of Toronto, Toronto, ON, Canada, 2Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON, Canada, 3Institute for Clinical Evaluative Sciences, Toronto, ON, Canada

    Background/Purpose: Symptomatic osteoarthritis (OA) and cardiovascular disease (CVD) commonly co-exist. Our aim was to determine the extent to which this relationship is explained by common…
  • Abstract Number: 1677 • 2015 ACR/ARHP Annual Meeting

    Disease-Regulated Expression of Anti-Inflammatory Interleukin-10 for the Treatment of Rheumatoid Arthritis

    Mathijs G.A. Broeren1, Miranda B. Bennink1, Onno J. Arntz2, Wim van den Berg2 and Fons A.J. van de Loo2, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, The Netherlands, Nijmegen, Netherlands, 2Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands

    Background/Purpose: The current treatment for patients with rheumatoid arthritis (RA) consists of biological drugs, often in combination with methotrexate. However, some patients fail to respond…
  • Abstract Number: 982 • 2015 ACR/ARHP Annual Meeting

    CD4+CD146+ T Cells: The Primed IL-17 Secreting Cells in the Pathogenesis of Psoriatic Arthritis

    Siba Raychaudhuri1 and Smriti K. Raychaudhuri2, 1Med/Rheumatology, Univ California Davis/VA Sacramento, Davis, CA, 2Rheumatology/Immunology, VA Sacramento Medical Center, Davis, CA

    Background/Purpose: CD146, also called melanoma cell adhesion molecule (MCAM), is a cell surface adhesion molecule.  A small minority of the T cell population also express…
  • Abstract Number: 1706 • 2015 ACR/ARHP Annual Meeting

    Prevalence and Factors Associated with Non-Traumatic Vertebral Fractures in Psoriatic Arthritis

    Shelly Chandran1, Sindhu R. Johnson2, Angela Cheung3, David Salonen4 and Dafna Gladman5, 1University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Dept of Rheumatology, Toronto Western and Mt. Sinai Hospitals, University of Toronto, Toronto, ON, Canada, 3Department of Medicine, University of Toronto, Toronto, ON, Canada, 4Department of Medical Imaging, University Health Network, Toronto, ON, Canada, 5Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: The prevalence of osteoporotic vertebral fractures (VF) in psoriatic arthritis (PsA) is not known. We aim to determine the prevalence and factors associated with…
  • Abstract Number: 984 • 2015 ACR/ARHP Annual Meeting

    Tofacitinib Inhibits Inflammation and New Bone Formation in Murine Spondyloarthritis but Does Not Adversely Inhibit Normal Human MSC Function

    Rik Lories1, Katelijne De Wilde2, Kerri Heritage1, Richard Cuthbert3, Elena Jones3, Karlijn Debusschere4, Dennis McGonagle3 and Dirk Elewaut5, 1Laboratory of Tissue Homeostasis and Disease, Skeletal Biology and Engineering Research Center, KU Leuven and University Hospitals Leuven., Leuven, Belgium, 2Laboratory for Molecular Immunology and Inflammation; Department of Rheumatology,, VIB, Ghent University and Ghent University Hospital, Ghent, Belgium, 3Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 4Laboratory for Molecular Immunology and Inflammation; Department of Rheumatology, VIB, Ghent University and Ghent University Hospital, Ghent, Belgium, 5Laboratory for Molecular Immunology and Inflammation, Department of Rheumatology, VIB, Ghent University and Ghent University Hospital, Ghent, Belgium

    Background/Purpose: Inflammation and new bone formation at entheseal sites are hallmarks of spondyloarthritis (SpA).  As TNF inhibition has only limited impact on new bone formation,…
  • Abstract Number: 1788 • 2015 ACR/ARHP Annual Meeting

    Lipoprotein Subfractions and Cardiovascular Disease in Systemic Lupus Erythematosus

    Simantini Sakhardande1, Monica Purmalek1, Maureen Sampson2, Yenealem Temesgen-Oyelakim3, Alice Fike4, Taufiq Salahuddin5, Balaji Natarajan5, Zerai Manna6, Elizabeth Joyal6, Marcus Chen5, Sarfaraz Hasni6, Nehal N. Mehta5,7, Alan Remaley5 and Mariana J. Kaplan1, 1Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2CC/NIH, Bethesda, MD, 3Office of the Clinical Director,National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 5NHLBI, National Institutes of Health, Bethesda, MD, 6National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 7National Heart Lung Blood Institute, Cardiovascular and Pulmonary Division, NHLBI, National Institutes of Health, Bethesda, MD

    Background/Purpose: Risk of atherosclerotic cardiovascular disease (CVD) is significantly enhanced in systemic lupus erythematosus (SLE) compared to age and gender matched controls. While this risk…
  • Abstract Number: 1006 • 2015 ACR/ARHP Annual Meeting

    Incident Frequent Knee Pain Is Associated with Changes in Semi-Quantitative Imaging Biomarkers of Inflammation

    C.Kent Kwoh1, Michael J. Hannon2, Tomoko Fujii3, Frank W Roemer4, Ali Guermazi5, David Hunter6, Felix Eckstein7 and Robert M. Boudreau8, 1Department of Medicine, The University of Arizona Arthritis Center and Division of Rheumatology, Tucson, AZ, 2Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 3University of Pittsburgh, Pittsburgh, PA, 4Department of Radiology, Boston University School of Medicine, Boston, MA, 5Boston University School of Medicine, Boston, MA, 6Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, 7Paracelsus Med Univ, Chondrometrics GmbH, Salzburg, Austria, 8Epidemiology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: The cause of knee pain in osteoarthritis (OA) is multi-factorial, and there is increasing evidence of the role of inflammation in OA. The goal…
  • Abstract Number: 1966 • 2015 ACR/ARHP Annual Meeting

    Active PMR and GCA Is Associated with Changes in Monocyte Subset Composition

    Qi Wang1, Kornelis S.M. van der Geest2, Wayel H. Abdulahad1, Johanna Westra3, Annemieke M.H. Boots1 and Elisabeth Brouwer1, 1Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 2Hanzeplein 1, Hpc: Aa21, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 3Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are two closely related syndromes affecting older people. Proinflammatory cytokine IL-6 is found increased in both…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 67
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology